Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European …
P Ljungman, R de la Camara, C Robin… - The Lancet infectious …, 2019 - thelancet.com
Cytomegalovirus is one of the most important infections to occur after allogeneic
haematopoietic stem cell transplantation (HSCT), and an increasing number of reports …
haematopoietic stem cell transplantation (HSCT), and an increasing number of reports …
Acute myeloid leukemia
H Döhner, DJ Weisdorf… - New England Journal of …, 2015 - Mass Medical Soc
Acute Myeloid Leukemia | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia
MM Berrien-Elliott, JA Foltz… - Science translational …, 2022 - science.org
Natural killer (NK) cells are innate lymphoid cells that eliminate cancer cells, produce
cytokines, and are being investigated as a nascent cellular immunotherapy. Impaired NK …
cytokines, and are being investigated as a nascent cellular immunotherapy. Impaired NK …
Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression
LP Wachsmuth, MT Patterson… - The Journal of …, 2019 - Am Soc Clin Investig
Posttransplantation cyclophosphamide (PTCy) recently has had a marked impact on human
allogeneic hematopoietic cell transplantation (HCT). Yet our understanding of how PTCy …
allogeneic hematopoietic cell transplantation (HCT). Yet our understanding of how PTCy …
Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-cell–replete haploidentical donor transplantation using post-transplant …
A Bashey, MJ Zhang, SR McCurdy… - Journal of Clinical …, 2017 - ascopubs.org
Purpose T-cell–replete HLA-haploidentical donor hematopoietic transplantation using post-
transplant cyclophosphamide was originally described using bone marrow (BM). With …
transplant cyclophosphamide was originally described using bone marrow (BM). With …
HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide
EJ Fuchs, SR McCurdy, SR Solomon… - Blood, The Journal …, 2022 - ashpublications.org
Hematopoietic cell transplantation from HLA-haploidentical related donors is increasingly
used to treat hematologic cancers; however, characteristics of the optimal haploidentical …
used to treat hematologic cancers; however, characteristics of the optimal haploidentical …
Modern approaches to HLA-haploidentical blood or marrow transplantation
CG Kanakry, EJ Fuchs, L Luznik - Nature reviews Clinical oncology, 2016 - nature.com
Allogeneic blood or bone-marrow transplantation (alloBMT) is a potentially curative
treatment for a variety of haematological malignancies and nonmalignant diseases …
treatment for a variety of haematological malignancies and nonmalignant diseases …
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors
AS Kanate, A Mussetti… - Blood, The Journal …, 2016 - ashpublications.org
We evaluated 917 adult lymphoma patients who received haploidentical (n= 185) or HLA-
matched unrelated donor (URD) transplantation either with (n= 241) or without …
matched unrelated donor (URD) transplantation either with (n= 241) or without …
Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched sibling donors: a Center for International Blood and …
Purpose Related donor haploidentical hematopoietic cell transplantation (Haplo-HCT) using
post-transplantation cyclophosphamide (PT-Cy) is increasingly used in patients lacking HLA …
post-transplantation cyclophosphamide (PT-Cy) is increasingly used in patients lacking HLA …
Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning
The key immunologic signatures associated with clinical outcomes after posttransplant
cyclophosphamide (PTCy)-based HLA-haploidentical (haplo) and HLA-matched bone …
cyclophosphamide (PTCy)-based HLA-haploidentical (haplo) and HLA-matched bone …